Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2
-
- András Váradi
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Gina F. Marrone
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Travis C. Palmer
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Ankita Narayan
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Márton R. Szabó
- Institute of Biochemistry, Biological Research Centre, Hungarian Academy of Sciences, Szeged, H-6726 Hungary
-
- Valerie Le Rouzic
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Steven G. Grinnell
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Joan J. Subrath
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Evelyn Warner
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Sanjay Kalra
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Amanda Hunkele
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Jeremy Pagirsky
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Shainnel O. Eans
- Department of Pharmacodyanamics, University of Florida, Gainesville, Florida 032610, United States
-
- Jessica M. Medina
- Department of Pharmacodyanamics, University of Florida, Gainesville, Florida 032610, United States
-
- Jin Xu
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Ying-Xian Pan
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Attila Borics
- Institute of Biochemistry, Biological Research Centre, Hungarian Academy of Sciences, Szeged, H-6726 Hungary
-
- Gavril W. Pasternak
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
-
- Jay P. McLaughlin
- Department of Pharmacodyanamics, University of Florida, Gainesville, Florida 032610, United States
-
- Susruta Majumdar
- Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
収録刊行物
-
- Journal of Medicinal Chemistry
-
Journal of Medicinal Chemistry 59 (18), 8381-8397, 2016-09-02
American Chemical Society (ACS)
